| Keyvan Rashidi, MD | |
|
725 E Market St, Akron, OH 44305-2421 | |
| (330) 434-4141 | |
| Not Available |
| Full Name | Keyvan Rashidi |
|---|---|
| Gender | Male |
| Speciality | Addiction Medicine |
| Experience | 8 Years |
| Location | 725 E Market St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417303082 | NPI | - | NPPES |
| 034777 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35.135041 (Ohio) | Secondary |
| 2083A0300X | Preventive Medicine - Addiction Medicine | 35.135041 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Counseling Center Of Ashtabula County | 7113830118 | 15 |
| Community Drug Board, Inc. | 8022061142 | 3 |
News Archive
Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.
Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
› Verified 6 days ago
| Entity Name | Community Counseling Center Of Ashtabula County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720029622 PECOS PAC ID: 7113830118 Enrollment ID: O20031106000414 |
News Archive
Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.
Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
› Verified 6 days ago
| Entity Name | Community Drug Board, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861566945 PECOS PAC ID: 8022061142 Enrollment ID: O20050301000178 |
News Archive
Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.
Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keyvan Rashidi, MD 725 E Market St, Akron, OH 44305-2421 Ph: (330) 434-4141 | Keyvan Rashidi, MD 725 E Market St, Akron, OH 44305-2421 Ph: (330) 434-4141 |
News Archive
Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.
Hemodiafiltration (HDF) for the treatment of end-stage renal disease patients is predominantly performed in European countries and in Japan, with some differences in technique such as rate of blood flow and dialysis fluid delivery systems.
Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.
› Verified 6 days ago
Dr. Richard Neil O'desky, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2554 Ira Rd, Akron, OH 44333 Phone: 330-666-5832 | |
Seth Michael Sigler, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-6119 Fax: 330-375-7813 | |
Richard L. Vincent, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 676 S Broadway St, Suite 200, Akron, OH 44311 Phone: 615-778-4066 Fax: 615-778-9114 | |
Marguerite Ann Erme, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1867 W Market St, Akron, OH 44313 Phone: 330-812-3865 Fax: 330-923-7558 | |
Dr. Stephen Gregory Kaiser, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, Summa Center For Corporate Health, Akron, OH 44310 Phone: 330-379-5959 Fax: 330-379-5902 | |
Anh Tu Tran, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Innovation Way, Akron, OH 44316 Phone: 330-796-6344 | |
Ray E Benson Iii, D.O. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Firestone Pkwy, Akron, OH 44301 Phone: 330-724-3345 |